Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11620 | 902 | 37.9 | 66% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
395 | 16247 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROLLINS 5119 | Address | 4 | 75% | 0% | 3 |
2 | ANTIPYRINE PHARMACOKINETICS | Author keyword | 2 | 67% | 0% | 2 |
3 | CYTOCHROME P4502B1 2 | Author keyword | 2 | 67% | 0% | 2 |
4 | PHYSIOL PHARM CLIN | Address | 2 | 67% | 0% | 2 |
5 | 9000 X G SUPERNATANT | Author keyword | 1 | 100% | 0% | 2 |
6 | CYTOCHROME P450 INFLAMMATION | Author keyword | 1 | 100% | 0% | 2 |
7 | IMMUNOPHYSIOL GEN COMPAREE | Address | 1 | 50% | 0% | 2 |
8 | PHARMACOINFORMAT MED UNIT | Address | 1 | 100% | 0% | 2 |
9 | REGULATORY STRATEGY | Address | 1 | 50% | 0% | 2 |
10 | CANC PHARMACOL UNIT | Address | 1 | 23% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIPYRINE PHARMACOKINETICS | 2 | 67% | 0% | 2 | Search ANTIPYRINE+PHARMACOKINETICS | Search ANTIPYRINE+PHARMACOKINETICS |
2 | CYTOCHROME P4502B1 2 | 2 | 67% | 0% | 2 | Search CYTOCHROME+P4502B1+2 | Search CYTOCHROME+P4502B1+2 |
3 | 9000 X G SUPERNATANT | 1 | 100% | 0% | 2 | Search 9000+X+G+SUPERNATANT | Search 9000+X+G+SUPERNATANT |
4 | CYTOCHROME P450 INFLAMMATION | 1 | 100% | 0% | 2 | Search CYTOCHROME+P450+INFLAMMATION | Search CYTOCHROME+P450+INFLAMMATION |
5 | HEPATIC DRUG METABOLISM | 1 | 27% | 0% | 3 | Search HEPATIC+DRUG+METABOLISM | Search HEPATIC+DRUG+METABOLISM |
6 | CYP3A2 | 1 | 15% | 1% | 6 | Search CYP3A2 | Search CYP3A2 |
7 | ADULT RAT HEPATOCYTE | 1 | 50% | 0% | 1 | Search ADULT+RAT+HEPATOCYTE | Search ADULT+RAT+HEPATOCYTE |
8 | BIO THERAPEUTICS | 1 | 50% | 0% | 1 | Search BIO+THERAPEUTICS | Search BIO+THERAPEUTICS |
9 | CYTOCHROME P450 3A2 CYP3A2 | 1 | 50% | 0% | 1 | Search CYTOCHROME+P450+3A2+CYP3A2 | Search CYTOCHROME+P450+3A2+CYP3A2 |
10 | DB PLUS MICE | 1 | 50% | 0% | 1 | Search DB++PLUS+MICE | Search DB++PLUS+MICE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERFERON MEDIATED DEPRESSION | 21 | 90% | 1% | 9 |
2 | CYTOCHROME P 450 GENE EXPRESSION | 11 | 54% | 2% | 14 |
3 | POLYRIBOINOSINIC ACID | 9 | 83% | 1% | 5 |
4 | LIVER DRUG METABOLISM | 8 | 70% | 1% | 7 |
5 | INTERFERON INDUCING AGENTS | 6 | 71% | 1% | 5 |
6 | ACID POLYRIBOCYTIDYLIC ACID | 6 | 100% | 0% | 4 |
7 | ASEPTIC INFLAMMATION | 6 | 100% | 0% | 4 |
8 | HEPATIC CYTOCHROME P450 | 5 | 15% | 3% | 27 |
9 | CYTOCHROME P450 GENE REGULATION | 4 | 75% | 0% | 3 |
10 | CYTOCHROME P450 REGULATION | 4 | 75% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Critical Review of Preclinical Approaches to Investigate Cytochrome P450-Mediated Therapeutic Protein Drug-Drug Interactions and Recommendations for Best Practices: A White Paper | 2013 | 7 | 57 | 74% |
Regulation of cytochrome P450 by inflammatory mediators: Why and how? | 2001 | 215 | 56 | 48% |
Regulation of drug-metabolizing enzymes and transporters in inflammation | 2006 | 154 | 150 | 35% |
Cytochrome P450 regulation and drug biotransformation during inflammation and infection | 2004 | 80 | 109 | 65% |
CYP-Mediated Therapeutic Protein-Drug Interactions Clinical Findings, Proposed Mechanisms and Regulatory Implications | 2010 | 27 | 42 | 67% |
Regulation of cytochromes P450 during inflammation and infection | 1997 | 282 | 239 | 51% |
Alteration of drug biotransformation and elimination during infection and inflammation | 2001 | 108 | 181 | 70% |
Can vaccines interact with drug metabolism? | 2015 | 1 | 53 | 58% |
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy | 2003 | 102 | 58 | 29% |
Mechanisms of Monoclonal Antibody-Drug Interactions | 2011 | 14 | 52 | 56% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ROLLINS 5119 | 4 | 75% | 0.3% | 3 |
2 | PHYSIOL PHARM CLIN | 2 | 67% | 0.2% | 2 |
3 | IMMUNOPHYSIOL GEN COMPAREE | 1 | 50% | 0.2% | 2 |
4 | PHARMACOINFORMAT MED UNIT | 1 | 100% | 0.2% | 2 |
5 | REGULATORY STRATEGY | 1 | 50% | 0.2% | 2 |
6 | CANC PHARMACOL UNIT | 1 | 23% | 0.6% | 5 |
7 | PHARM PHAMACOKINET | 1 | 40% | 0.2% | 2 |
8 | SAFETY ASSESSMENT TRADIT CHINESE MED | 1 | 27% | 0.3% | 3 |
9 | CENTOCOR RD | 1 | 50% | 0.1% | 1 |
10 | CLIN PHARMACOL EARLY DEV | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000102102 | TRIMETHADIONE//ZAKLAD CHEM FIZJOL//ZAKLAD CHEM FIZJOLOGICZNEJ |
2 | 0.0000075936 | BURSAL DISEASE VIRUS BDV//VIRUS VACCINE THERAPY//DECOMPENSATED HEPATITIS |
3 | 0.0000074232 | PREGNANE X RECEPTOR//PXR//CONSTITUTIVE ANDROSTANE RECEPTOR |
4 | 0.0000072384 | CYP2C12//ONE DAY TREATMENT//S BIOCHEM |
5 | 0.0000072214 | DICROCOELIUM DENDRITICUM//SISTEMAS PROD SANIDAD ANIM//DICROCOELIUM CHINENSIS |
6 | 0.0000069728 | ALPHA NAPHTHYLISOTHIOCYANATE//IDIOSYNCRATIC DRUG INDUCED LIVER INJURY//IDIOSYNCRATIC ADVERSE DRUG REACTIONS |
7 | 0.0000064723 | ASAN FDN//DA 125//MED DIAGNOST PATHOL |
8 | 0.0000059690 | MARIE LOWE COMPARAT ONCOL//CYP2D//MARI LOWE COMPARAT ONCOL |
9 | 0.0000054575 | SERUM MEDIATORS//LY2216684//NEPHROLOGY CLINICAL PRACTICE GUIDELINES |
10 | 0.0000053246 | LIVER CARCINOGEN METABOLIZING ENZYMES//ARYL HYDROCARBON HYDROXYLASE//DEMETHYLASES |